Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped it gain global recognition for its multiple drug candidates and targets in the therapeutic areas of cancer, anxiety,... Read more
Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland,... Read more
Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interference... Read more
Dr Silviu Itescu formed Mesoblast in 2004 to commercialize orthopedic applications of proprietary adult stem cell technology. As the CEO... Read more
A Quinquagenarian from Australia, Dr Silviu Itescu, is based out of the US and has been traveling tirelessly between New York and Melbourne... Read more
Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a company that "reverse... Read more
Biopsy has been used as a gold standard for determining the extent of liver disease. But this method has its limitations and many times... Read more
Using its proprietary platform technology Oncoprint, India-based Mitra Biotech is developing personalized treatment options for cancer,... Read more
Publicly-held biotech company TaiMed Biologics was set up in 2007 with the mission to discover, develop and deliver innovative medicines... Read more
Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has been working on bringing... Read more
Due to the rising costs in drug discovery and development and a large proportion of drug failure being associated with absorption, distribution,... Read more
Korea-based LegoChem Biosciences (LCB) was started in 2006 with the objective to accelerate discovery and development of new small molecule... Read more
Survey Box